Skip to main content
Log in

ARHGAP17 Inhibits Hepatocellular Carcinoma Progression by Inactivation of Wnt/β-Catenin Signaling Pathway

  • Original Article
  • Published:
Biochemical Genetics Aims and scope Submit manuscript

Abstract

As a member of Rho GAPs family, Rho GTPase-Activating Protein 17 (ARHGAP17) regulates cytoskeletal recombination, cell polarity, cell proliferation and cell migration. ARHGAP17 is identified as a tumor suppressor in numerous cancer types. Current study intends to examine ARHGAP17 expression and its possible influence on the progression of hepatocellular carcinoma (HCC). ARHGAP17 expression in HCC cells was verified by RT-PCR and western blot. The proliferation and invasion of HCC cells were evaluated by CCK8 assay and transwell assay, respectively. The mRNA expression of ARHGAP17, PCNA, E-cadherin, N-cadherin, β-catenin, GSK-3β, Axin1, and APC were detected by RT-PCR. The protein expression of ARHGAP17, PCNA, E-cadherin, N-cadherin, β-catenin, p-β-catenin, GSK-3β, p-GSK-3β, Axin1, and APC were detected by western blot. ARHGAP17 staining was evaluated by immunohistochemistry and immunofluorescence. ARHGAP17 expression decreased significantly in HCC tumors and HCC cells after EMT. In response to overexpression of ARHGAP17, the capacities of HCC cell proliferation and invasion were reduced significantly, which were also confirmed by tumorigenesis experiments in vivo. With overexpression of ARHGAP17 in HCC cells, the p-GSK3β/GSK3β decreased, while the p-β-catenin/β-catenin, Axin1 and APC increased. In conclusion, ARHGAP17 inhibits HCC progression by inactivating the Wnt/β-catenin signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data Availability

All data generated or analyzed during this study are included in this published article.

References

  • Braun AC, Olayioye MA (2015) Rho regulation: Dlc proteins in space and time. Cell Signal 27:1643–1651

    Article  CAS  PubMed  Google Scholar 

  • Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301–1314

    Article  PubMed  Google Scholar 

  • Ghouri YA, Mian I, Rowe JH (2017) Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinog 16:1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gomaa W, Al-Maghrabi H, Al-Maghrabi J (2021) The prognostic significance of immunostaining of Wnt signalling pathway molecules, E-cadherin and β-catenin in colorectal carcinomacolorectal carcinoma. Arab J Gastroenterol 22:137–145

    Article  PubMed  Google Scholar 

  • Gumbiner BM (2005) Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 6:622–634

    Article  CAS  PubMed  Google Scholar 

  • Guo Q, Xiong Y, Song Y, Hua K, Gao S (2019) ARHGAP17 suppresses tumor progression and up-regulates P21 and P27 expression via inhibiting PI3K/AKT signaling pathway in cervical cancer. Gene 692:9–16

    Article  CAS  PubMed  Google Scholar 

  • Hao Y, Baker D, Ten Dijke P (2019) TGF-β-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci 20:2767

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jaffe AB, Hall A (2005) Rho gtpases: biochemistry and biology. Annu Rev Cell Dev Biol 21:247–269

    Article  CAS  PubMed  Google Scholar 

  • Jiang W, He T, Liu S, Zheng Y, Xiang L, Pei X, Wang Z, Yang H (2018) The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer. J Hematol Oncol 11:139

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim JG, Mahmud S, Min JK, Lee YB, Kim H, Kang DC, Park HS, Seong J, Park JB (2021) RhoA GTPase phosphorylated at tyrosine 42 by src kinase binds to β-catenin and contributes transcriptional regulation of vimentin upon Wnt3A. Redox Biol 40:101842

    Article  CAS  PubMed  Google Scholar 

  • Klauzinska M, Castro NP, Rangel MC, Spike BT, Gray PC, Bertolette D, Cuttitta F, Salomon D (2020) The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition. Semin Cancer Biol 29:51–58

    Article  Google Scholar 

  • Kreider-Letterman G, Castillo A, Mahlandt EK, Goedhart J, Rabino A, Goicoechea S, Garcia-Mata R (2023) ARHGAP17 regulates the spatiotemporal activity of Cdc42 at invadopodia. J Cell Biol 222:e202207020

    Article  CAS  PubMed  Google Scholar 

  • Malfettone A, Soukupova J, Bertran E et al (2017) Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma. Cancer Lett 392:39–50

    Article  CAS  PubMed  Google Scholar 

  • McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73:4–13

    Article  CAS  PubMed  Google Scholar 

  • Pan S, Deng Y, Fu J, Zhang Y, Zhang Z, Ru X, Qin X (2018) Tumor suppressive role of ARHGAP17 in colon cancer through Wnt/β-Catenin signaling. Cell Physiol Biochem 46:2138–2148

    Article  CAS  PubMed  Google Scholar 

  • Park SY, Jeong MS, Han CW, Yu HS, Jang SB (2016) Structural and functional insight into proliferating cell nuclear antigen. J Microbiol Biotechnol 26:637–647

    Article  CAS  PubMed  Google Scholar 

  • Rabaan AA, Al-Ahmed SH, Bazzi AM, Alfouzan WA, Alsuliman SA, Aldrazi FA, Haque S (2020) Overview of hepatitis C infection, molecular biology, and new treatment. J Infect Public Health 13:773–783

    Article  PubMed  Google Scholar 

  • Ravi A, Kaushik S, Ravichandran A, Pan CQ, Low BC (2015) Epidermal growth factor activates the rho gtpase-activating protein (gap) deleted in liver cancer 1 via focal adhesion kinase and protein phosphatase 2a. J Biol Chem 290:4149–4162

    Article  CAS  PubMed  Google Scholar 

  • Richnau N, Aspenström P (2001) Rich, a rho GTPase-activating protein domain-containing protein involved in signaling by Cdc42 and Rac1. J Biol Chem 27:35060–35070

    Article  Google Scholar 

  • Sengez B, Carr BI, Alotaibi H (2022) EMT and inflammation: crossroads in HCC. J Gastrointest Cancer. https://doi.org/10.1007/s12029-021-00801-z

    Article  PubMed  Google Scholar 

  • Shao S, Zhao X, Zhang X, Luo M, Zuo X, Huang S, Wang Y, Gu S, Zhao X (2015) Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Mol Cancer 14:28

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sribenja S, Sawanyawisuth K, Kraiklang R, Wongkham C, Vaeteewoottacharn K, Obchoei S, Yao Q, Wongkham S, Chen C (2013) Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma. BMC Cancer 13:430

    Article  PubMed  PubMed Central  Google Scholar 

  • Tian Q, Gao H, Zhou Y, Zhu L, Yang J, Wang B, Liu P, Yang J (2022) RICH1 inhibits breast cancer stem cell traits through activating kinases cascade of Hippo signaling by competing with Merlin for binding to Amot-p80. Cell Death Dis 13:71

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tripathi BK, Qian X, Mertins P, Wang D, Papageorge AG, Carr SA, Lowy DR (2014) Cdk5 is a major regulator of the tumor suppressor dlc1. J Cell Biol 207:627–642

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang J, He H, Jiang Q, Wang Y, Jia S (2020a) CBX6 promotes HCC metastasis via transcription factors Snail/Zeb1-mediated EMT mechanism. Onco Targets Ther 13:12489–12500

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang L, Yang X, Wan L, Wang S, Pan J, Liu Y (2020b) ARHGAP17 inhibits pathological cyclic strain-induced apoptosis in human periodontal ligament fibroblasts via Rac1/Cdc42. Clin Exp Pharmacol Physiol 47:1591–1599

    Article  CAS  PubMed  Google Scholar 

  • Wong SHM, Fang CM, Chuah LH, Leong CO, Ngai SC (2018) E-cadherin: its dysregulation in carcinogenesis and clinical implications. Crit Rev Oncol Hematol 121:11–22

    Article  PubMed  Google Scholar 

  • Yang S, Liu Y, Li MY et al (2017) FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer. Mol Cancer 16:124

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhang Y, Wang X (2020) Targeting the Wnt/β-catenin signaling pathway in cancer. J Hematol Oncol 13:165

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhang J, Wang J, Zhou YF, Ren XY, Lin MM, Zhang QQ, Wang YH, Li X (2015) Rich1 negatively regulates the epithelial cell cycle, proliferation and adhesion by CDC42/RAC1-PAK1-Erk1/2 pathway. Cell Signal 27:1703–1712

    Article  CAS  PubMed  Google Scholar 

  • Zhang Y, Li S, Zhou X, Sun J, Fan X, Guan Z, Zhang L, Yang Z (2019) Construction of a targeting nanoparticle of 3’,3”-bis-peptide-siRNA conjugate/mixed lipid with postinserted DSPE-PEG2000-cRGD. Mol Pharm 16:4920–4928

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by the Natural Science Foundation of Liaoning Province (2019-ZD-1062), the Joint Program of Key R&D Programs of Liaoning Province (2020JH2/10300168), Medical and Industrial Cross Joint Project of Liaoning Province (2022-YGJC-11) and the R&D Project for Major Technological Innovations of Shenyang City (19-112-4-081).

Author information

Authors and Affiliations

Authors

Contributions

HZ, SF, and WZ conceived and designed the experiments. CL, MS, FC analyzed the data. CL, YZ, BN, HZ performed the experiments. The manuscript was written by HZ, SF, and WZ. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Wei Zhang.

Ethics declarations

Competing interests

The author reports no conflicts of interest in this work.

Ethical Approval

Current study was approved by the Ethics Committee of the General Hospital of Northern Theater Command of PLA.

Informed Consent

Written informed consent was obtained from the parents.

Consent for Publication

The authors affirm that human research participants provided informed consent for publication of the images.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fan, S., Zhao, H., Li, C. et al. ARHGAP17 Inhibits Hepatocellular Carcinoma Progression by Inactivation of Wnt/β-Catenin Signaling Pathway. Biochem Genet (2024). https://doi.org/10.1007/s10528-024-10822-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10528-024-10822-5

Keywords

Navigation